mifepristone has been researched along with Insulin Resistance in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (15.00) | 18.2507 |
| 2000's | 6 (30.00) | 29.6817 |
| 2010's | 9 (45.00) | 24.3611 |
| 2020's | 2 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrews, ZB; Cowley, MA; Dodd, GT; Eramo, M; Henry, BA; Mitchell, CA; Tiganis, T; Xirouchaki, CE | 1 |
| Datta, K; Kumar, S; Saha, P; Tyagi, RK | 1 |
| Grewal, S; Gubbi, S; McGlotten, R; Muniyappa, R; Nieman, LK; Sharma, ST | 1 |
| Chadarevian, R; Debono, M; Eastell, R; Newell-Price, J; Ross, RJ | 1 |
| Colleran, K; Gross, C; Molitch, ME; Purnell, JQ; Wallia, A | 1 |
| Bae, JH; Cho, YS; Park, SY | 1 |
| Hasan, AU; Hashimoto, T; Igarashi, J; Kohno, M; Kosaka, H; Nagai, Y; Ohmori, K; Yamashita, T | 1 |
| Akiyama, N; Akiyama, Y; Asakura, K; Hanasaki, K; Imagawa, K; Kato, H; Kuroda, T; Murayama, T; Ono, T; Shinosaki, T | 1 |
| Beaudry, JL; Belanoff, JK; Dunford, EC; Hunt, H; Riddell, MC; Teich, T; Zaharieva, D | 1 |
| Beaudry, JL; Belanoff, JK; Dunford, EC; Hunt, H; Pivovarov, JA; Porras, DP; Riddell, MC; Teich, T | 1 |
| Anuradha, CV; Priyadarshini, E | 1 |
| Li, L; Messina, JL; Thompson, LH; Zhao, L | 1 |
| Auwerx, J; Lydon, J; O'Malley, BW; Picard, F; Schoonjans, K; Wanatabe, M | 1 |
| Ishizawa, M; Ishizuka, T; Kajita, K; Kawai, Y; Miura, A; Morita, H; Natsume, Y; Uno, Y; Yasuda, K | 1 |
| Andrew, R; Homer, NZ; Karpe, F; Stimson, RH; Tan, GD; Wake, DJ; Walker, BR | 1 |
| Cooney, GJ; Hara, T; Kusunoki, M; Storlien, LH | 1 |
| Alam, T; Chen, L; McCorkle, K; McGarry, JD; Ogawa, A; Ohneda, M; Pieber, TR; Stein, DT; Unger, RH | 1 |
| Ishizawa, M; Ishizuka, T; Itaya, S; Kajita, K; Kanoh, Y; Miura, A; Murase, H; Nagashima, T; Yamamoto, M; Yasuda, K | 1 |
| Anil Kumar, KL; Marita, AR | 1 |
| Bitar, MS | 1 |
3 trial(s) available for mifepristone and Insulin Resistance
| Article | Year |
|---|---|
Mifepristone Improves Adipose Tissue Insulin Sensitivity in Insulin Resistant Individuals.
Topics: Adipose Tissue; Adult; Aged; Cross-Over Studies; Double-Blind Method; Female; Glucose Intolerance; Humans; Insulin Resistance; Insulin Secretion; Male; Middle Aged; Mifepristone; Obesity; Overweight; Prediabetic State; United States | 2021 |
Mifepristone reduces insulin resistance in patient volunteers with adrenal incidentalomas that secrete low levels of cortisol: a pilot study.
Topics: Adrenal Gland Neoplasms; Aged; Biomarkers, Tumor; Female; Humans; Hydrocortisone; Hypothalamus; Insulin Resistance; Male; Middle Aged; Mifepristone; Pilot Projects; Pituitary-Adrenal System; Safety | 2013 |
Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonists on 11beta-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue in men.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Adult; Aged; Cortisone; Cross-Over Studies; Double-Blind Method; Enzyme Inhibitors; Fenofibrate; Gas Chromatography-Mass Spectrometry; Hormone Antagonists; Humans; Hydrocortisone; Hypolipidemic Agents; Insulin Resistance; Kinetics; Liver; Male; Metyrapone; Microdialysis; Middle Aged; Mifepristone; Obesity; PPAR alpha; PPAR gamma; Rosiglitazone; Subcutaneous Fat; Thiazolidinediones | 2007 |
17 other study(ies) available for mifepristone and Insulin Resistance
| Article | Year |
|---|---|
Intranasal Targeting of Hypothalamic PTP1B and TCPTP Reinstates Leptin and Insulin Sensitivity and Promotes Weight Loss in Obesity.
Topics: Adipose Tissue, White; Administration, Intranasal; Animals; Blood-Brain Barrier; Cholestanes; Diet, High-Fat; Feeding Behavior; Gliosis; Glucocorticoids; Hypothalamus; Insulin Resistance; Leptin; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mifepristone; Obesity; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Protein Tyrosine Phosphatase, Non-Receptor Type 2; Spermine; Weight Loss | 2019 |
Upsurge in autophagy, associated with mifepristone-treated polycystic ovarian condition, is reversed upon thymoquinone treatment.
Topics: Androgens; Animals; Autophagy; Beclin-1; Benzoquinones; Disease Models, Animal; eIF-2 Kinase; Female; Gene Expression Regulation; Granulosa Cells; Humans; Insulin Resistance; Mifepristone; Ovary; Ovulation; Polycystic Ovary Syndrome; Rats; Receptors, Androgen | 2021 |
Improvement in insulin sensitivity during mifepristone treatment of Cushing syndrome: early and late effects.
Topics: Cushing Syndrome; Glucose Tolerance Test; Hormone Antagonists; Humans; Insulin Resistance; Mifepristone | 2013 |
Cortisone induces insulin resistance in C2C12 myotubes through activation of 11beta-hydroxysteroid dehydrogenase 1 and autocrinal regulation.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Autocrine Communication; Cell Line; Cortisone; Glucocorticoids; Glucose; Glycyrrhetinic Acid; Humans; Hydrocortisone; Insulin; Insulin Resistance; Mifepristone; Muscle Fibers, Skeletal; Receptors, Glucocorticoid | 2014 |
Mifepristone promotes adiponectin production and improves insulin sensitivity in a mouse model of diet-induced-obesity.
Topics: 3T3-L1 Cells; Adiponectin; Adipose Tissue; Animals; Cell Differentiation; Diet, High-Fat; Disease Models, Animal; Insulin Resistance; Male; Mice; Mifepristone; Obesity | 2013 |
Pharmacological evaluation of adipose dysfunction via 11β-hydroxysteroid dehydrogenase type 1 in the development of diabetes in diet-induced obese mice with cortisone pellet implantation.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Adipose Tissue; Animals; Cortisone; Diabetes Mellitus, Experimental; Diet, High-Fat; Glucocorticoids; Glucose; Insulin Resistance; Mice; Mice, Inbred C57BL; Mifepristone; Obesity; Receptors, Glucocorticoid; Up-Regulation | 2014 |
Effects of selective and non-selective glucocorticoid receptor II antagonists on rapid-onset diabetes in young rats.
Topics: Animals; Blood Glucose; Body Weight; Corticosterone; Diabetes Mellitus, Experimental; Diet, High-Fat; Hormone Antagonists; Insulin; Insulin Resistance; Male; Mifepristone; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid; Small Molecule Libraries | 2014 |
Glucocorticoid antagonism limits adiposity rebound and glucose intolerance in young male rats following the cessation of daily exercise and caloric restriction.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Adiposity; Animals; Blood Glucose; Blotting, Western; Body Weight; Caloric Restriction; Gluconeogenesis; Glucose Intolerance; Glucose Tolerance Test; Glycogen; Glycogenolysis; Hormone Antagonists; Insulin; Insulin Resistance; Intra-Abdominal Fat; Lipolysis; Liver; Male; Mifepristone; Physical Conditioning, Animal; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid | 2016 |
Glucocorticoid Antagonism Reduces Insulin Resistance and Associated Lipid Abnormalities in High-Fructose-Fed Mice.
Topics: Animals; Fatty Acids, Nonesterified; Fructose; Glucocorticoids; Insulin Resistance; Lipid Metabolism; Lipids; Male; Mice; Mifepristone; Receptors, Glucocorticoid; Triglycerides | 2017 |
Tissue-specific difference in the molecular mechanisms for the development of acute insulin resistance after injury.
Topics: Acute Disease; Animals; Corticosterone; Fatty Acids, Nonesterified; Hemorrhage; Hormone Antagonists; Insulin; Insulin Resistance; Liver; Male; Metyrapone; Mifepristone; Muscle, Skeletal; Phosphoserine; Rats; Rats, Sprague-Dawley; Signal Transduction; Wounds and Injuries | 2009 |
Progesterone receptor knockout mice have an improved glucose homeostasis secondary to beta -cell proliferation.
Topics: Animals; Blood Glucose; Cell Count; Cell Division; Cell Size; Diabetes Mellitus, Experimental; Diabetes, Gestational; Female; Glucose; Glucose Tolerance Test; Homeostasis; Hormone Antagonists; Hyperglycemia; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mifepristone; Organ Size; Pregnancy; Progesterone; Receptors, Progesterone; Sex Characteristics; Signal Transduction | 2002 |
Inhibition of PKCbeta improves glucocorticoid-induced insulin resistance in rat adipocytes.
Topics: Adipocytes; Animals; Cycloheximide; Dexamethasone; Dose-Response Relationship, Drug; Enzyme Inhibitors; Genes, Dominant; Glucocorticoids; Hormone Antagonists; Insulin Resistance; Male; Mifepristone; Protein Kinase C; Protein Kinase C beta; Protein Synthesis Inhibitors; Rats; Rats, Wistar; Receptors, Glucocorticoid; Time Factors; Transfection | 2002 |
Amelioration of high-fat feeding-induced insulin resistance in skeletal muscle with the antiglucocorticoid RU486.
Topics: Animals; Blood Glucose; Dietary Fats; Glucose; Glucose Clamp Technique; Insulin; Insulin Resistance; Male; Mifepristone; Muscle, Skeletal; Rats; Rats, Wistar | 1995 |
Amylin-insulin relationships in insulin resistance with and without diabetic hyperglycemia.
Topics: Amyloid; Animals; Dexamethasone; Diabetes Mellitus, Type 2; Hyperglycemia; Insulin; Insulin Resistance; Insulin Secretion; Islet Amyloid Polypeptide; Male; Mifepristone; Obesity; Pancreas; Rats; Rats, Wistar; Rats, Zucker; Receptors, Glucocorticoid; RNA, Messenger; Somatostatin | 1993 |
Effect of glucocorticoid receptor antagonist RU 38486 on acute glucocorticoid-induced insulin resistance in rat adipocytes.
Topics: Adipocytes; Animals; Biological Transport; Brain; Deoxyglucose; Dexamethasone; Glucocorticoids; Hormone Antagonists; Insulin; Insulin Resistance; Isoenzymes; Male; Mifepristone; Muscle Proteins; Muscle, Skeletal; Prednisolone; Protein Kinase C; Rats; Rats, Wistar; Receptors, Glucocorticoid; Time Factors | 1997 |
Troglitazone prevents and reverses dexamethasone induced insulin resistance on glycogen synthesis in 3T3 adipocytes.
Topics: 3T3 Cells; Abortifacient Agents, Steroidal; Adipocytes; Animals; Binding Sites; Chromans; Dexamethasone; Dose-Response Relationship, Drug; Drug Interactions; Glucocorticoids; Glycogen; Hypoglycemic Agents; Insulin; Insulin Resistance; Iodine Radioisotopes; Mice; Mifepristone; Thiazoles; Thiazolidinediones; Troglitazone | 2000 |
Co-administration of etomoxir and RU-486 mitigates insulin resistance in hepatic and muscular tissues of STZ-induced diabetic rats.
Topics: Animals; Carnitine O-Palmitoyltransferase; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Enzyme Inhibitors; Epoxy Compounds; Fatty Acids, Nonesterified; Glucose; Hormone Antagonists; Insulin Resistance; Liver; Male; Mifepristone; Mitochondria; Muscle, Skeletal; Rats; Rats, Wistar | 2001 |